| [1] |
Li Jianqin, Sheng Yueyue, Zhou Yinmin, Shi Weiqing, Yang Xingchen.
Safety of clopidogrel combined with statins on acute coronary syndrome in patients based on metabolic pathways by different cytochrome P450 enzyme: a Meta analysis
[J]. Clinical Focus, 2022, 37(2): 101-105.
|
| [2] |
Cui Guoyan, Zheng Wen, Zhang Liwei.
Clinical efficacy of lidocaine combined with rosuvastatin in treating acute coronary syndrome concurrent with acute arrhythmia among patients intolerant of amiodarone
[J]. Clinical Focus, 2021, 36(4): 311-314.
|
| [3] |
Liu Yuanliang, Li Biao, Jiang Zuofeng, Zhu Youfeng, Zhang Shaoheng, Wang Yarong, Li Rongseng, Li Li.
Efficacy and safety of half-dose versus standard-dose of tirofiban for percutaneous coronary intervention in elderly Chinese patients with acute coronary syndrome: a meta-analysis
[J]. Clinical Focus, 2021, 36(11): 965-971.
|
| [4] |
Qiu Siyue1, Yang Haiyu2, Yu Tao2, Huang Zhichao1, Zhang Zixin1.
Impact of estimated glomerular filtration rate on nosocomial prognosis in patients with acute coronary syndrome
[J]. Clinical Focus, 2020, 35(6): 498-502.
|
| [5] |
Zhang Han, Shi Yunke, Zhang Min, Cai Hongyan, Li Jian, .
The influence of family stress on the quality of life and physical recovery of male and female patients with acute coronary syndrome
[J]. Clinical Focus, 2020, 35(12): 1078-1083.
|
| [6] |
He Zhengfei, Wang Diqing, He Xiaolan, Sun Linggang.
Related factors of slow coronary flowno reflow after percutaneous coronary angioplasty for acute coronary syndrome
[J]. Clinical Focus, 2020, 35(11): 971-975.
|
| [7] |
Li Liang Wang Mei.
Research progress on antiplatelet therapy in special populations of acute coronary syndrome
[J]. Clinical Focus, 2018, 33(9): 767-770.
|
| [8] |
Rao Mingyue, Wang Yaling, Zhang Guoru, Wang Mei.
Advances in anticoagulant therapy after acute coronary syndrome
[J]. Clinical Focus, 2018, 33(9): 761-766.
|
| [9] |
Pan Guangjie，Chen Huili，Gu Yunfei，Liu Lei，Chen Yan，Li Songsen，Ma Huifang，Jin Jun，Zhang Shouyan.
Current situation and related factors of coronary intervention treatment in patients with non STelevation acute coronary syndrome
[J]. Clinical Focus, 2017, 32(7): 591-594.
|
| [10] |
Xia Jinggang， Xu Ji， Hao Hengjian， Yin Chunlin， Xu Dong.
Relationship between apolipoprotein E gene polymorphism and shortterm prognosis in patients with acute coronary syndrome
[J]. Clinical Focus, 2017, 32(7): 579-582.
|
| [11] |
Teng Xin1， Qin Qin2， Lu Yaru2， Yang Ning2.
Relation between platelet parameters and clinical classification and severity of acute coronary syndrome
[J]. Clinical Focus, 2017, 32(6): 487-490.
|
| [12] |
Liu Xiaoyu，Jia Guowei，Sun Rongguo，Ma Bocong，Zhao Ming，Zhang Hongbin，Zhang Wei.
Ticagrelor and clopidogrel on PCI perioperative hsCRP in patients with acute coronary syndrome
[J]. Clinical Focus, 2017, 32(5): 421-424.
|
| [13] |
Wang Yanbo，Gu Xinshun，Hao Guozhen，Jiang Yunfa，Fan Weize，Fu Xianghua.
Incidence and risk factors of type 1 cardiorenal syndrome in patients with acute coronary syndrome
[J]. Clinical Focus, 2017, 32(4): 310-313.
|
| [14] |
Hu Zhiling1， Li Fang2， Li Xiang2， Wang Xiaowei3， Yang Shuang2.
Predictive value of two methods of platelet function detection for VerifyNow and Multiplate in patients with acute coronary syndrome
[J]. Clinical Focus, 2017, 32(12): 1049-1052.
|
| [15] |
Liu Jinming， Li Fang， Xie Yanan.
Progress in treatment strategies of patients with acute coronary
[J]. Clinical Focus, 2016, 31(6): 600-605.
|
